共 175 条
[1]
Seminerio JL(2015)Impact of obesity on the management and clinical course of patients with inflammatory bowel disease Inflamm Bowel Dis 21 2857-2863
[2]
Harper JW(2013)Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients Inflamm Bowel Dis 19 2118-2124
[3]
Sinanan MN(2012)Development and validation of a bariatric surgery morbidity risk calculator using the prospective, multicenter NSQIP dataset Aliment Pharmacol Ther 35 335-341
[4]
Zisman TL(2011)Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial J Am Coll Surg 212 301-309
[5]
Bultman E(2018)Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial JAMA 319 255-265
[6]
Gupta PK(2018)Bariatric surgery in patients with inflammatory bowel disease: an accessible path? Report of a case series and review of the literature JAMA 319 241-254
[7]
Franck C(2015)Inflammatory bowel disease is not a contraindication for bariatric surgery J Crohns Colitis 9 185-190
[8]
Miller WJ(2018)Outcomes of bariatric surgery in patients with inflammatory bowel disease Obes Surg 28 1681-1687
[9]
Gupta H(2016)Short-term outcomes of inflammatory bowel disease after Roux-en-Y gastric bypass vs sleeve gastrectomy Obes Surg 26 1186-1190
[10]
Forse RA(2019)The role of bariatric surgery in morbidly obese patients with inflammatory bowel disease J Am Coll Surg 228 893-901